Marissa Zupancic is JURIST’s Washington DC Correspondent, a JURIST Senior Editor and a 3L at the University of Pittsburgh School of Law. She’s stationed in Washington during her Semester in DC. Today I attended oral arguments at the US Supreme Court for Food and Drug Administration v. Alliance for Hippocratic Medicine. The case concerns whether the [...]
Search Results for: Food AND Drug Administration
Explainer: Supreme Court Prepares for Oral Arguments in Latest Reproductive Rights Case
The US Supreme Court hears arguments Tuesday in a case concerning the authorization and regulation of the abortion pill mifepristone at a time when reproductive rights are at the heart of political division and changing policies across the nation. At the center of the case is the Alliance for Hippocratic Medicine’s lawsuit against the Food [...]
DC dispatch: senators push for prescription patent reform at Capitol Hill panel
Marissa Zupancic is JURIST’s Washington DC Correspondent, a JURIST Senior Editor and a 3L at the University of Pittsburgh School of Law. She’s stationed in Washington during her Semester in DC. US Senators Peter Welch (D-VT) and Amy Klobuchar (D-MN) hosted a panel discussion earlier this month highlighting new bipartisan legislation to address pharmaceutical drug [...]
Class Action Asserts Patient Rights Violated: Genzyme Faces Legal Scrutiny Over Fabry Drug Handling
The US has faced numerous issues involving prescription drugs, especially with rising costs and accessibility of life-saving and required medications. One class action lawsuit (Wilkins et. al. v. Genzyme Corporation (n/k/Sanofi) against Genzyme (now owned by and known as Sanofi, the eighth largest pharmaceutical company in the world) alleges the company intentionally misled patients with [...]
US Supreme Court to consider restricting access to widely used abortion drug
The US Supreme Court agreed on Wednesday to hear two cases regarding access to the drug mifepristone, which is widely prescribed for abortions and miscarriages. The court previously allowed the drug to remain on the market while the cases wound their way through the appellate process in the US Court of Appeals for the Fifth [...]
Joshua Villanueva is a JURIST Assistant Editor and a 2L at UC Law San Francisco (formerly UC Hastings), He files this dispatch from San Francisco. The recently-concluded Asia-Pacific Economic Cooperation (APEC) leaders’ summit, originally designed to address economic challenges in the Asia-Pacific region, found itself overshadowed by the unfolding drama of the US-China relationship. As [...]
This Day in History: The Law of Gobblers and Other Tasty Sides
It is Thanksgiving Day. The aroma of turkey; of dressing; candied sweet potatoes; green bean casserole; cranberry sauce; freshly baked yeast rolls; giblet gravy, and of pies emanating from the kitchen fills our nostrils. Home is the place to be today. But have you ever given thought to the law of the gobbler? This Day in [...]
The US Court of Appeals for the Fifth Circuit ruled Wednesday to restrict the use of mifepristone, an abortion pill, by prohibiting its delivery by mail or prescription via telemedicine. However, the ruling will not take immediate effect due to an April ruling from the US Supreme Court temporarily protecting access to the drug. The [...]
American Red Cross eases restrictions on gay and bisexual men blood donations
The American Red Cross implemented guidance from the US Food and Drug Administration (FDA) on Monday to relax restrictions on blood donations for gay and bisexual men. Specifically, the American Red Cross changed its donor assessment questionnaire to remove gender and sexual orientation-specific questions and focus more on an individual’s history. Before, gay and bisexual [...]
US Supreme Court upholds mifepristone access amid ongoing battle for reproductive rights
The US Supreme Court ruled Friday that abortion pill mifepristone will continue to be widely accessible as the ongoing appeals process takes place. Mifepristone, approved in 2000, is used broadly to end pregnancies. The FDA’s approval was challenged by doctors and medical groups claiming the drug regimen was “unsafe.” On April 7, a Texas federal [...]